Clinical trial
S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian…
NCT00023634 · SWOG Cancer Research Network, Other · Terminated
Key facts
| NCT number | NCT00023634 |
|---|---|
| Title | S0114 Vaccine Therapy in Treating Patients With Gastric, Prostate, or Ovarian Cancer |
| Official title | An Early Phase Study of an EGFRvIII Peptide Based Vaccine in Patients With EGFRvIII Expressing Cancers |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Terminated |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Brain Tumors, Gastric Cancer, Ovarian Cancer, Prostate Cancer |
| Intervention type | Biological |
| Interventions | KLH, GMCSF |
| Enrollment | 14 |
| Start date | Jun 1, 2001 |
| Primary completion | Nov 1, 2008 |
| Completion | Nov 1, 2008 |
| First posted | Jan 27, 2003 |
| Last update posted | Mar 6, 2015 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: